Hirokazu Miki
- Molecular Biology
- Biomedical Engineering top 5%
- Biomaterials top 5%
- Oncology top 10%
- Hematology top 5%
- Co-authors
- Masahiro AbeShuji OzakiToshio MatsumotoKoichiro HayashiMichihiro NakamuraKazunori IshimuraWataru SakamotoToshinobu Yogo
- Topics
- Multiple Myeloma Research and Treatments (29 papers)Peptidase Inhibition and Analysis (9 papers)Cancer Mechanisms and Therapy (6 papers)
- Cited by
- BiomaterialsHematologyOncology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hirokazu Miki
74 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 508
- Biomedical Engineering 501
- Biomaterials 368
- Oncology 327
- Hematology 299
Countries citing papers authored by Hirokazu Miki
This map shows the geographic impact of Hirokazu Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Miki more than expected).
Fields of papers citing papers by Hirokazu Miki
This network shows the impact of papers produced by Hirokazu Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Miki. The network helps show where Hirokazu Miki may publish in the future.
Co-authorship network of co-authors of Hirokazu Miki
This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Miki. A scholar is included among the top collaborators of Hirokazu Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Miki. Hirokazu Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | 1 | |
| 10 | 6 | |
| 11 | 4 | |
| 12 | 32 | |
| 13 | Glutamic Acid Has a Liver-Protective Effect through the Suppression of Inducible Nitric Oxide Synthase in Primary Cultured Rat Hepatocytes | 2 |
| 14 | 13 | |
| 15 | 20 | |
| 16 | 262 | |
| 17 | 25 | |
| 18 | 4 | |
| 19 | 108 | |
| 20 | 42 |
About Hirokazu Miki
Hirokazu Miki is a scholar working on Hematology, Oncology and Biochemistry, having authored 81 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Peptidase Inhibition and Analysis (9 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Biomaterials (368 citations), Hematology (299 citations) and Oncology (327 citations). Hirokazu Miki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masahiro Abe, Shuji Ozaki, Toshio Matsumoto, Koichiro Hayashi, Michihiro Nakamura, Kazunori Ishimura, Wataru Sakamoto, Toshinobu Yogo, Shingen Nakamura and Kumiko Kagawa. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.